175 results
8-K
EX-10.1
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
or Maintaining SOFR Loans
Increased Costs; Capital Adequacy
Taxes; Withholding, Etc.
Obligation to Mitigate; Replacement of Lenders
Tax Treatment … of Direction
Compliance Certificate
Assignment Agreement
E-1
U.S. Tax Compliance Certificate
E-2
U.S. Tax Compliance Certificate
E-3
U.S. Tax Compliance
8-K
EX-10.2
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the Securities and the consequences … . The Investor and each Account understands that it should consult with its own tax advisors in order to determine the U.S. federal, state and local tax
8-K
EX-4.2
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect … executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
8-K
EX-4.1
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
Force Majeure
Section 18.16 Calculations
Section 18.17 USA PATRIOT Act
Section 18.18 Tax Withholding
Section 18.19 Applicability of Waivers Under … support with respect to any material indebtedness of the Company or any Affiliate of the Company that is a U.S. person for U.S. tax purposes and cannot
8-K
EX-10.4
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
Investor has made its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the 2029 Convertible Notes … with an investment in the 2029 Convertible Notes. The 2029 Convertible Note Investor understands that it should consult with its own tax advisors
8-K
EX-99.1
wj8z7whku4d50ftu
8 May 24
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:47am
8-K
EX-99.1
e316mk
29 Feb 24
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
7:35am
8-K
EX-99.1
2v3sdg dqhblz7w
2 Nov 23
Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
nzkd5hzfkw1ywet44kcp
2 Aug 23
Karyopharm Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
4im3 r8mo
4 May 23
Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:53am